Friday, July 25, 2014 7:50:44 PM
Revenue growth is stalling relative to the branch expansion. In fact, the revenue of the most recent 15 branches is a lot less than the first 14 branches this same time last year and that's if we assume that the first 14 branches didn't increase revenue at all from last year.
Let's also talk financing.
Convertible debt with steep financing costs has trippled from the third quarter of 2013. The AS has doubled. There are no prime loans. There is no buyout.
Add to that the "old, stale, and really boring" discussion about the CEO repeatedly failing to meet payroll tax obligations that potentially put his clients at risk and the discussion gets really juicy, doesn't it?
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM